Cell Line, TumorImmunity, InnateMice, Inbred C57BL
Dr. Marka Rae Crittenden, MD, PhD
NPI1619187143PAC ID9234278656
- Medicare services, 2024
- 347
- Medicare patients, 2024
- 110
- Part D claims, 2024
- 106
- Publications
- 68
- Clinical trials
- 5
- Practice address
- 4805 NE Glisan Street, Portland, OR 97213
- Practice phone
- Call (503) 215-1111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Crittenden's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Marka Rae Crittenden is a radiation oncologist in Portland, Oregon
Dr. Crittenden practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
Dr. Crittenden's NPI, 1619187143, was assigned on May 23, 2007. Dr. Crittenden graduated from Mayo Medical School in 2004. Dr. Crittenden holds Oregon license MD150151.
NPI and contact details
- NPI
- 1619187143NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9234278656
- NPI enumeration date
- May 23, 2007
- NPI status
- Active
- Practice phone
- (503) 215-1111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Marka Rae Crittenden practices at Providence Portland Medical Center in Portland, Oregon
Dr. Crittenden's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.
- Providence Portland Medical Center4805 NE Glisan Street, Portland, OR 97213 · Multnomah CountyPhone(503) 215-1111
Source: Dmand AI Affiliation Data
Dr. Marka Rae Crittenden is affiliated with 1 site of care and 1 medical group
Dr. Crittenden's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. The medical group on file is The Oregon Clinic.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Marka Rae Crittenden's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crittenden practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Portland Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Crittenden practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Providence Health & Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Marka Rae Crittenden is one of 98 radiation oncologists in Oregon
Radiation oncology is Dr. Crittenden's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Crittenden is licensed in Oregon.
Specialties and state licenses
- Radiation oncology, OregonPrimary
Radiation oncologists near Dr. Crittenden
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
98radiation oncologists in Oregon47radiation oncologists in Portland7radiation oncologists at Providence Portland Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Marka Rae Crittenden billed Medicare for 347 services in 2024
CMS data shows 347 Medicare services from Dr. Crittenden across 8 procedure codes in 2024, for 110 Medicare patients. Medicare paid $15,940 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2024347
Medicare patients110
Paid by Medicare$15,940
Procedure codes8
Dr. Crittenden's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 2972024: 2922%
- Office and hospital visits
- 2023: 362024: 5553%
Dr. Crittenden compared with the Oregon median for radiation oncologists, 2024
- Dr. Crittenden
- Oregon median
- Medicare services
- 347vs 83959% below
- Medicare patients
- 110vs 14021% below
- Part D claims
- 14vs 4770% below
Medians across 99 radiation oncologists in Oregon with Dmand AI profiles that report each measure.
Dr. Crittenden's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Crittenden?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Crittenden and other radiation oncologists in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Marka Rae Crittenden treated 110 Medicare patients in 2024, average age 72
CMS counts 110 Medicare patients who saw Dr. Crittenden in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have cancer, and 61% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Crittenden's median patient age at 71, with 61% women.
Medicare patients, 2024110
Average age72
Average risk score1.51
Also on Medicaid12%
Dr. Crittenden's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Crittenden's Medicare patients by sex, 2024
- Women5853%
- Men5247%
Chronic conditions among Dr. Crittenden's Medicare patients, 2024
- Cancer75%
- High blood pressure61%
- High cholesterol58%
- Arthritis27%
- Chronic kidney disease27%
- Diabetes25%
- Mood disorders25%
- Depression24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Crittenden's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women61%
- Men39%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Marka Rae Crittenden wrote 106 Medicare Part D claims in 2024
In 2024, Dr. Crittenden wrote 106 Medicare Part D claims for 54 patients. 75% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $250 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.
Part D claims, 2024106
Drugs named by CMS1
Total drug cost$250
Part D patients54
Dr. Crittenden's Part D claims by kind of drug, 2024
- Generic80 claims75%
- Brand-name26 claims25%
Dr. Crittenden's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 272024: 1448%
Drugs named by CMS: 1 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find radiation oncologists like Dr. Crittenden by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Marka Rae Crittenden has 68 publications on record
Dmand AI links 68 papers to Dr. Crittenden, published from 2010 to 2024. 2022 was the busiest year, with 7. The most frequent topics are Immunotherapy, Cell Line, Tumor and Mice, Inbred C57BL. Dr. Crittenden has published most often in PLoS One. Dr. Crittenden's most frequent co-authors are Kristina Hoot Young, MD, PhD, Rom Samuel Leidner, MD and Brendan David Curti, MD.
Papers68
Years published2010 to 2024
Dr. Crittenden's papers by year, 2015 to 2024
Topics Dr. Crittenden writes about most
- Immunotherapy
- Cell Line, Tumor
- Mice, Inbred C57BL
- CD8-Positive T-Lymphocytes
- Pancreatic Neoplasms
- T-Lymphocytes
- Tumor Microenvironment
- Adaptive Immunity
Dr. Crittenden's most frequent co-authors
- Kristina Hoot Young, MD, PhD21 shared papers
- Rom Samuel Leidner, MD13 shared papers
- Brendan David Curti, MD11 shared papers
Recent publications by Dr. Crittenden
AgingGlucocorticoidsHyperplasia
CD8-Positive T-LymphocytesCell Line, TumorCell Tracking
Adjuvants, ImmunologicCD8-Positive T-LymphocytesMice, Inbred C57BL
Int Rev Cell Mol Biol
Adaptive ImmunityAntigen PresentationDendritic Cells
See who Dr. Crittenden researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Crittenden works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Marka Rae Crittenden has worked on 5 clinical trials
Dmand AI links Dr. Crittenden to 5 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Glioblastoma and Neoplasm Metastasis. Providence Health & Services sponsors the most, 5.
Clinical trials with Dr. Crittenden by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Crittenden's trials
- Carcinoma, Renal Cell
- Glioblastoma
- Neoplasm Metastasis
- Rectal Neoplasms
- Squamous Cell Carcinoma of Head and Neck
Investigators on the most trials with Dr. Crittenden
- Steven Kysung Seung, MD, PhD5 shared trials
- Matthew Curtis Solhjem, MD5 shared trials
- Alice Wang-Chesebro, MD5 shared trials
Recent clinical trials with Dr. Crittenden
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma (opens in a new tab)
Active, not recruitingPhase 2
Rectal NeoplasmsRectal DiseasesLY2157299CapecitabineFluorouracil
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer (opens in a new tab)
Active, not recruitingPhase 2
Carcinoma, Renal CellKidney NeoplasmsSBRTHigh Dose IL-2
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (opens in a new tab)
Active, not recruitingPhase 1/2
Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellNivolumabRadiation (3 days)Radiation (5 days)
GlioblastomaAstrocytomaAntibioticsCohort 1Cohort 2
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions (opens in a new tab)
CompletedPhase 1
Neoplasm MetastasisNeoplastic ProcessesMEDI6469
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Marka Rae Crittenden received $29,767 in industry payments from 2016 to 2022
CMS Open Payments shows 24 general payments to Dr. Crittenden from 10 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 91% of the total. Genentech, Inc. paid the most, $19,140. It also lists 15 research payments totaling $2,702 from 2018 to 2020.
General payments to Dr. Crittenden by program year, 2016 to 2022
General payments to Dr. Crittenden by kind, 2016 to 2022
$29.8Kin total
- Consulting fees$27,14091%
- Travel and lodging$1,4535%
- Food and beverage$1,1744%
Companies that paid Dr. Crittenden the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Marka Rae Crittenden graduated from Mayo Medical School
Dr. Crittenden graduated from Mayo Medical School in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Marka Rae Crittenden's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Marka Rae Crittenden
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Marka Rae Crittenden's NPI number?
Dr. Marka Rae Crittenden's NPI number is 1619187143. It was assigned on May 23, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Marka Rae Crittenden?
Dr. Marka Rae Crittenden is a radiation oncologist in Portland, Oregon. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Marka Rae Crittenden practice?
Dr. Crittenden practices at 4805 NE Glisan Street, Portland, OR 97213. Dr. Crittenden's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
What is Dr. Marka Rae Crittenden's office phone number?
The practice phone on file for Dr. Crittenden is (503) 215-1111.
What is Dr. Marka Rae Crittenden's medical license number?
Dr. Crittenden holds Oregon license MD150151.
Which hospitals is Dr. Marka Rae Crittenden affiliated with?
Dr. Crittenden practices at Providence Portland Medical Center in Portland, Oregon.
What medical group is Dr. Marka Rae Crittenden part of?
Dr. Crittenden is linked to The Oregon Clinic.
Does Dr. Marka Rae Crittenden accept Medicare?
Yes. CMS data shows Dr. Crittenden billed Medicare for 347 services in 2024.
How many Medicare patients does Dr. Marka Rae Crittenden see?
CMS counts 110 Medicare patients who saw Dr. Crittenden in 2024, with an average age of 72.
What services does Dr. Marka Rae Crittenden bill to Medicare?
In 2024, Dr. Crittenden's most billed Medicare services were radiation oncology (77014), radiation oncology (77334) and radiation oncology (77300).
Show 6 more questionsShow fewer questions
Where did Dr. Marka Rae Crittenden go to medical school?
Dr. Crittenden graduated from Mayo Medical School in 2004.
What drugs does Dr. Marka Rae Crittenden prescribe most?
In 2024 Medicare Part D data, Dr. Crittenden's most prescribed drugs by claims were Levothyroxine Sodium.
Has Dr. Marka Rae Crittenden received payments from drug or device companies?
CMS Open Payments shows $29,767 in general payments to Dr. Crittenden from 10 companies from 2016 to 2022. The largest total came from Genentech, Inc.
How long has Dr. Marka Rae Crittenden been practicing?
Dr. Crittenden graduated from medical school in 2004, 22 years ago.
Does Dr. Marka Rae Crittenden do research?
Dmand AI links 68 publications to Dr. Crittenden, published from 2010 to 2024. Dr. Crittenden has worked on 5 clinical trials.
Who does Dr. Marka Rae Crittenden publish with?
Dr. Crittenden's most frequent co-authors are Kristina Hoot Young, MD, PhD (21 shared papers), Rom Samuel Leidner, MD (13 shared papers) and Brendan David Curti, MD (11 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card